SCOTTISH RE GROUP LIMITED CONSOLIDATED FINANCIAL STATEMENTS MARCH 31, 2017

Transcription

1 CONSOLIDATED FINANCIAL STATEMENTS MARCH 31, 2017 (These consolidated financial statements are unaudited.)

2 Table of Contents Consolidated Balance Sheets (unaudited) and December 31, Consolidated Statements of Comprehensive Income Three month periods ended and 2016 (unaudited)... 3 Consolidated Statements of Shareholders Deficit Three month periods ended and 2016 (unaudited)... 4 Consolidated Statements of Cash Flows Three month periods ended and 2016 (unaudited)... 5 Notes to Consolidated Financial Statements (unaudited)

3 CONSOLIDATED BALANCE SHEETS (Expressed in Thousands of United States Dollars, except share data) March 31, 2017 (Unaudited) December 31, 2016 (Audited) Assets Fixed-maturity investments held as trading securities, at fair value... $ 948,482 $ 1,000,889 Fixed-maturity investments held as available-for-sale securities, at fair value (amortized cost: 2017 $540,948; 2016 $477,409) , ,128 Common stock investments held as available-for-sale securities, at fair value (cost: 2017 $15,914)... 15,970 - Cash and cash equivalents , ,920 Other investments... 2,325 2,368 Funds withheld at interest , ,761 Total investments ,056,385 2,039,066 Accrued interest receivable ,005 9,219 Amounts recoverable from reinsurers , ,536 Reinsurance balances receivable , ,882 Deferred acquisition costs... 22,310 23,531 Other assets... 1,031 1,290 Total assets... $ 2,800,192 $ 2,920,524 Liabilities Reserves for future policy benefits... $ 1,309,048 $ 1,392,659 Interest-sensitive contract liabilities , ,610 Collateral finance facility, net of debt issuance costs , ,978 Reinsurance balances payable , ,739 Accounts payable and other liabilities , ,858 Embedded derivative liabilities, at fair value... 13,282 15,640 Long-term debt, at par value... 86,500 86,500 Total liabilities... 2,847,802 $ 2,952,984 Shareholders Deficit Ordinary shares, par value $0.01: 218,383,370 shares issued and outstanding... 2,184 2,184 Non-cumulative perpetual preferred shares, par value $0.01: 3,246,776 shares issued and outstanding... 81,169 81,169 Additional paid-in capital... 1,772,547 1,772,547 Accumulated other comprehensive income (loss), net of taxes and deferred acquisition costs... 3, Retained deficit... (1,906,729) (1,888,988) Total shareholders deficit... (47,610) (32,460) Total liabilities and total shareholders deficit... $ 2,800,192 $ 2,920,524 1 Includes total investments of consolidated variable interest entity ( VIE )... $ 282,844 $ 278,216 2 Includes accrued interest receivable of consolidated VIE... 1,349 1,326 3 Reflects collateral finance facility, net of debt issuance costs, of consolidated VIE , ,056 4 Reflects accounts payable and other liabilities of consolidated VIE... 81,717 76,602 See Accompanying Notes to Consolidated Financial Statements (Unaudited) 2

4 CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (UNAUDITED) (Expressed in Thousands of United States Dollars) Three month period ended March 31, 2017 March 31, 2016 Revenues Premiums earned, net... $ 68,744 $ 78,321 Investment income, net... 15,003 16,851 Net realized and unrealized gains (losses)... 7,325 (3,423) Change in fair value of embedded derivative assets and liabilities... 2,358 (5,960) Fees and other income Total revenues... 93,893 86,273 Benefits and expenses Claims, policy benefits, and changes in policyholder reserves, net... 86,620 83,433 Interest credited to interest-sensitive contract liabilities... 4,991 5,474 Other insurance expenses, including amortization and release of deferred acquisition costs, net... 10,427 7,102 Operating expenses... 5,066 4,456 Collateral finance facilities expense... 3,357 2,911 Interest expense... 1,173 1,003 Total benefits and expenses , ,379 Income (loss) before income taxes... (17,741) (18,106) Income tax benefit (expense)... - (206) Net income (loss)... (17,741) (18,312) Other comprehensive income (loss), net: Unrealized gains (losses) on available-for-sale investments, net of taxes and deferred acquisition costs... 2,591 6,290 Total other comprehensive income (loss), net... 2,591 6,290 Total comprehensive income (loss)... $ (15,150) $ (12,022) See Accompanying Notes to Consolidated Financial Statements (Unaudited) 3

5 CONSOLIDATED STATEMENTS OF SHAREHOLDERS' DEFICIT (UNAUDITED) (Expressed in Thousands of United States Dollars) Three month period ended March 31, March 31, Share capital: Ordinary shares: Beginning and end of period... $ 2,184 $ 684 Non-cumulative perpetual preferred shares: Beginning and end of period... 81,169 81,169 Additional paid-in capital: Beginning and end of period... 1,772,547 1,218,190 Accumulated other comprehensive income (loss): Beginning of period (4,718) Other comprehensive income (loss), net of taxes and deferred acquisition costs... 2,591 6,290 End of period... 3,219 1,572 Retained deficit: Beginning of period... (1,888,988) (1,680,837) Net income (loss)... (17,741) (18,312) End of period... (1,906,729) (1,699,149) Total shareholders deficit... $ (47,610) $ (397,534) See Accompanying Notes to Consolidated Financial Statements (Unaudited) 4

6 CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) (Expressed in Thousands of United States Dollars) Three month period ended March 31, 2017 March 31, 2016 Operating activities Net income (loss)... $ (17,741) $ (18,312) Adjustments to reconcile net income (loss) to net cash used in operating activities: Net realized and unrealized (gains) losses... (7,325) 3,423 Changes in value of embedded derivative assets and liabilities... (2,358) 5,960 Amortization (accretion) of fixed-maturity investments available-for-sale Amortization of deferred acquisition costs... 1,221 (660) Amortization of deferred finance facility costs Changes in assets and liabilities: Funds withheld at interest... 4,073 11,806 Accrued interest receivable (284) Reinsurance balances receivable... 71,810 5,148 Other assets... (21) 192 Reserves for future policy benefits, net of amounts recoverable from reinsurers... (19,464) 11,642 Interest-sensitive contract liabilities... (5,042) (10,071) Accounts payable and other liabilities, including deferred tax liabilities... 3,647 3,932 Reinsurance balances payable... (10,070) (1,006) Net cash used in operating activities... 19,323 12,028 Investing activities Purchase of fixed-maturity investments available-for-sale... (74,462) (77,053) Purchase of common stock investments available-for-sale... (15,914) - Proceeds from sales and maturities of fixed-maturity investments trading... 59,742 47,710 Proceeds from sales and maturities of fixed-maturity investments available-for-sale... 10,686 2,198 Purchases of and proceeds from affiliated investments, net... - (298) Purchase of and proceeds from other investments, net Net cash provided by investing activities... (19,906) (27,253) Financing activities Withdrawals from interest-sensitive contract liabilities... (7,902) (11,708) Net cash used in financing activities... (7,902) (11,708) Net change in cash and cash equivalents... (8,485) (26,933) Cash and cash equivalents, beginning of period , ,277 Cash and cash equivalents, end of period... $ 186,435 $ 139,344 See Accompanying Notes to Consolidated Financial Statements (Unaudited) 5

7 1. Organization, Business Strategy, and Lines of Business Organization Scottish Re Group Limited ( SRGL and, together with SRGL s consolidated subsidiaries and, as a result of the application of FASB ASC (as defined in Note 2, Basis of Presentation herein), its consolidated VIE*, as applicable, the Company, we, our, and us ) is a holding company incorporated under the laws of the Cayman Islands, and with its principal executive office located in Bermuda. Through its operating subsidiaries, the Company is principally engaged in the reinsurance of life insurance, annuities, and annuity-type products. All of the equity voting power of SRGL, along with the right to designate a controlling number of members of SRGL s Board of Directors (the Board ), is controlled directly or indirectly by MassMutual Capital Partners LLC, a member of the MassMutual Financial Group ( MassMutual Capital ) and SRGL Acquisition, LDC, an affiliate of Cerberus Capital Management L.P. ( Cerberus and, together with MassMutual Capital, the Investors ). As of, SRGL s consolidated subsidiaries (consisting of operating companies, holding companies, and financing companies) and its consolidated VIE (a collateral finance facility), by jurisdiction, were as follows: Bermuda Scottish Re Life (Bermuda) Limited ( SRLB ) Cayman Islands Scottish Annuity & Life Insurance Company (Cayman) Ltd. ( SALIC ) Ireland Scottish Re (Dublin) dac ( SRD ) Orkney Re II plc ( Orkney Re II )* Luxembourg Scottish Financial (Luxembourg) S.á r.l. ( SFL ) United States of America ( U.S. or United States ) Scottish Holdings, Inc. ( SHI ) Scottish Re (U.S.), Inc. ( SRUS ) * Orkney Re II is the consolidated VIE. References in the consolidated financial statements and accompanying notes to any discretionary acts of management or of any of the consolidated entities do not, unless explicitly stated otherwise, refer to any such acts by Orkney Re II. Business Strategy In 2008, our insurance operating companies ceased writing new business and notified existing clients that new reinsurance risks no longer would be accepted under existing reinsurance treaties, thereby placing the reinsurance business into run-off (the Closed Block ). We continue to manage the Closed Block, performing key activities and actively managing the business under the terms of the related reinsurance treaties. Lines of Business As defined and described in our audited consolidated financial statements and accompanying notes thereto for the year ended December 31, 2016, we have written reinsurance business that is wholly or partially retained in one or more of our reinsurance subsidiaries and have classified the reinsurance as Traditional Solutions or as Financial Solutions. 6

8 1. Organization, Business Strategy, and Lines of Business (continued) Going Concern These consolidated financial statements have been prepared using accounting principles applicable to a going concern, which contemplates the realization of assets and the satisfaction of liabilities and commitments in the normal course of business. The Company s management assesses whether conditions and events raise substantial doubt that the Company will be able to continue as a going concern. Assessment of whether substantial doubt exists requires management to evaluate whether conditions and events, considered in the aggregate, indicate that it is probable that the Company will be unable to meet its obligations as they become due within one year of the issuance of the consolidated financial statements. Our ability to continue as a going concern is, therefore, dependent upon our ability to successfully meet our obligations, satisfy ongoing regulatory requirements and maintain adequate capital and liquidity. As disclosed in the SRGL s audited consolidated financial statements and accompanying notes thereto for the year ended December 31, 2016, adverse mortality experience on the Traditional Solutions yearly renewable term ( YRT ) business has had a substantial negative impact on the operating results. Absent a significant improvement in the performance on the YRT business during the remainder of 2017, the Company will incur additional capital strain, thereby further reducing available funds and eroding the Company s ability to pay the deferred interest on the Capital and Trust Preferred Securities (as defined herein) as such deferred interest payments become due during the first quarter of Accordingly, substantial doubt exists that the Company will be able to meet these deferred interest payments. Management continues to monitor and evaluate alternatives to the current situation, however, there currently are no strategies that both are probable of effectively being implemented and that would supply funds in such amounts and at such times as would be necessary to mitigate the conditions and events described above. These consolidated financial statements do not give effect to any adjustments to recorded amounts and their classification which would be necessary if a liquidation of the Company was imminent. Should this occur, we would be required to realize our assets and discharge our liabilities and commitments in other than the normal course of business and at amounts different from those reflected in the consolidated financial statements. For further discussion on the Going Concern, please refer to Note 11, Subsequent Events Going Concern. 2. Basis of Presentation Accounting Principles Our consolidated interim financial statements are prepared in accordance with U.S. Generally Accepted Accounting Principles ( U.S. GAAP ). Accordingly, these consolidated interim financial statements do not include all of the information and notes required by U.S. GAAP for annual financial statements. These unaudited consolidated interim financial statements should be read in conjunction with SRGL s audited consolidated financial statements and accompanying notes thereto for the year ended December 31, Consolidation The consolidated interim financial statements include the assets, liabilities, and results of operations of SRGL, its subsidiaries, and the VIE for which we are the primary beneficiary, as defined in Financial Accounting Standards Board ( FASB ) Accounting Standards Codification ( ASC ) Subtopic , Consolidation Overall. All significant intercompany transactions and balances have been eliminated in consolidation. 7

9 2. Basis of Presentation (continued) We currently consolidate one non-recourse securitization, Orkney Re II, a special purpose VIE incorporated under the laws of Ireland. For further discussion on Orkney Re II, please refer to Note 5, Collateral Finance Facility and Securitization Structure. Estimates and Assumptions The preparation of consolidated interim financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the amounts reported in the consolidated interim financial statements and accompanying notes. Actual results could differ materially from those estimates and assumptions used by management, and such estimates and assumptions could change in the future as more information becomes known, which could impact the amounts reported and disclosed herein. Our most significant assumptions are for: investment valuations; accounting for embedded derivative instruments; assessment of risk transfer for structured insurance and reinsurance contracts; estimates of premiums; reserves for future policy benefits; retrocession arrangements and amounts recoverable from reinsurers; interest-sensitive contract liabilities; and current taxes, deferred taxes, and the determination of associated valuation allowances. Where applicable, management periodically reviews and revises these estimates, as appropriate. Any adjustments made to these estimates are reflected in the period in which the estimates are revised. 3. Investments Trading Investments The estimated fair values of our fixed-maturity investments held as trading securities as of and December 31, 2016, were as follows: March 31, 2017 December 31, 2016 U.S. Treasury securities and U.S. government agency obligations... $ 16,502 $ 17,682 Corporate securities , ,161 Municipal bonds... 26,119 26,167 Residential mortgage-backed securities , ,126 Commercial mortgage-backed securities , ,129 Asset-backed securities , ,624 Total trading securities... $ 948,482 $ 1,000,889 8

10 3. Investments (continued) The contractual maturities of the fixed-maturity investments held as trading securities as of and December 31, 2016, were as follows (actual maturities may differ as a result of calls and prepayments): Estimated Fair Value Estimated Fair Value March 31, 2017 December 31, 2016 Due in one year or less... $ 40,049 $ 34,631 Due after one year through five years , ,056 Due after five years through ten years... 54,134 62,898 Due after ten years... 39,382 43, , ,010 Residential mortgage-backed securities , ,126 Commercial mortgage-backed securities , ,129 Asset-backed securities , ,624 Total trading securities... $ 948,482 $ 1,000,889 Available-for-Sale Investments The amortized cost and estimated fair value of fixed-maturity and common stock securities classified as available-for-sale as of and December 31, 2016, were as follows: Cost or Amortized Cost Gross Unrealized Temporary Losses Other Than Temporary Losses Estimated Fair Value Gains U.S. Treasury securities and U.S. government agency obligations... $ 23,701 $ - $ (55) $ - $ 23,646 Corporate securities ,199 4,304 (889) - 300,614 Municipal bonds... 2, (1) - 2,580 Residential mortgage-backed securities... 12, (46) - 12,236 Commercial mortgage-backed securities... 26, (339) - 25,938 Asset-backed securities , (178) - 179,471 Total fixed-maturity securities ,948 5,045 (1,508) - 544,485 Common stock... 15, ,970 Total available-for-sale securities... $ 556,862 $ 5,101 $ (1,508) $ - $ 560,455 9

11 3. Investments (continued) Cost or Amortized Cost December 31, 2016 Gross Unrealized Temporary Losses Other Than Temporary Losses Estimated Fair Value Gains U.S. Treasury securities and U.S. government agency obligations... $ 23,701 $ - $ (66) $ - $ 23,635 Corporate securities ,453 2,710 (1,706) - 286,457 Municipal bonds Residential mortgage-backed securities... 4, (39) - 4,448 Commercial mortgage-backed securities... 25, (476) - 25,670 Asset-backed securities , (226) - 137,918 Total available-for-sale securities... $ 477,409 $ 3,232 $ (2,513) $ - $ 478,128 The estimated fair value and gross unrealized losses of all investments classified as available-for-sale, aggregated by investment category and length of time that individual securities have been in a continuous unrealized loss position, as of and December 31, 2016, were as follows: Less than 12 months 12 months or more Total Estimated Fair Value Unrealized Losses Estimated Fair Value Unrealized Losses Estimated Fair Value Unrealized Losses U.S. Treasury securities and U.S. government agency obligations... $ 23,646 $ (55) $ - $ - $ 23,646 $ (55) Corporate securities... 75,621 (853) 1,460 (36) 77,081 (889) Municipal bonds (1) (1) Residential mortgage-backed securities... 2,942 (46) - - 2,942 (46) Commercial mortgage-backed securities... 11,333 (250) 1,751 (89) 13,084 (339) Asset-backed securities... 26,953 (67) 13,781 (111) 40,734 (178) Total fixed-maturity securities ,901 (1,272) 16,992 (236) 157,893 (1,508) Common stock Total available-for-sale securities... $ 140,901 $ (1,272) $ 16,992 $ (236) $ 157,893 $ (1,508) 10

12 3. Investments (continued) December 31, 2016 Less than 12 months 12 months or more Total Estimated Fair Value Unrealized Losses Estimated Fair Value Unrealized Losses Estimated Fair Value Unrealized Losses U.S. Treasury securities and U.S. government agency obligations... $ 23,635 $ (66) $ - $ - $ 23,635 $ (66) Corporate securities... 98,857 (1,660) 1,450 (46) 100,307 (1,706) Municipal bonds Residential mortgage-backed securities (39) (39) Commercial mortgage-backed securities... 10,101 (340) 1,705 (136) 11,806 (476) Asset-backed securities... 28,033 (151) 22,035 (75) 50,068 (226) Total fixed-maturity securities ,605 (2,256) 25,190 (257) 186,795 (2,513) Common stock Total available-for-sale securities... $ 161,605 $ (2,256) $ 25,190 $ (257) $ 186,795 $ (2,513) The total number of securities classified as available-for-sale that had unrealized losses as of and December 31, 2016, were 119 and 155, respectively. The Company s unrealized losses on its fixed-maturity investments were the result of interest rate increases. Since the decline in estimated fair value is attributable to changes in interest rates and not credit quality, and the Company has the intent and ability to hold these maturities through a recovery of unrealized losses, or until maturity of the individual securities, the Company does not consider these investments other than temporarily impaired. The contractual maturities of the fixed-maturity investments classified as available-for-sale securities as of and December 31, 2016, were as follows (actual maturities may differ as a result of calls and prepayments): Cost or Amortized Cost Estimated Fair Value March 31, 2017 March 31, 2017 Due in one year or less... $ 6,053 $ 6,049 Due after one year through five years , ,239 Due after five years through ten years , ,721 Due after ten years... 10,464 10, , ,840 Residential mortgage-backed securities... 12,248 12,236 Commercial mortgage-backed securities... 26,034 25,938 Asset-backed securities , ,471 Total fixed-maturity available-for-sale securities... $ 540,948 $ 544,485 11

13 3. Investments (continued) Cost or Amortized Cost Estimated Fair Value December 31, 2016 December 31, 2016 Due in one year or less... $ 5,156 $ 5,160 Due after one year through five years , ,072 Due after five years through ten years , ,338 Due after ten years... 8,424 8, , ,092 Residential mortgage-backed securities... 4,477 4,448 Commercial mortgage-backed securities... 25,932 25,670 Asset-backed securities , ,918 Total fixed-maturity available-for-sale securities... $ 477,409 $ 478,128 Assets on Deposit We are required to maintain assets on deposit with various U.S. regulatory authorities, in accordance with the statutory regulations of the individual jurisdictions, to support our insurance and reinsurance operations. As a result of the various regulatory limitations on how these assets may be invested and their unavailability for general corporate purposes, these assets are considered restricted. We also have established trust funds* in connection with certain transactions for the benefit of the transaction counterparties, which amounts also include assets attributable to the VIE that we consolidate, Orkney Re II. As a result of the restrictions imposed on the foregoing assets in accordance with the respective reinsurance treaties and other agreements to which they relate, these assets (including the assets within the collateral finance facility that are held for the contractual obligations of that structure) are not available for general corporate purposes and also are considered restricted. (Please also refer to Note 5, Collateral Finance Facility and Securitization Structure for additional information.) The estimated fair value of the components of the restricted assets as of and December 31, 2016, were as follows: March 31, 2017 December 31, 2016 Deposits with U.S. regulatory authorities... $ 4,579 $ 4,578 Trust funds* attributable to VIE , ,957 Trust funds* , ,511 Total... $ 1,267,203 $ 1,092,046 * Trust funds in the above table reflects the fair value of assets held by ceding companies under modified coinsurance arrangements and the fair value of assets we hold in segregated portfolios under coinsurance arrangements. The assets that comprise the Trust funds are included in fixed-maturity investments held as trading securities, fixed-maturity investments held as available-for-sale securities, common stock investments held as available-for-sale securities, cash and cash equivalents, and funds withheld at interest in the Consolidated Balance Sheets. 12

14 3. Investments (continued) Net Investment Income Net investment income on investments and other balances for the three month periods ended and 2016, was derived from the following sources: Three Month Period Ended Three Month Period Ended March 31, 2016 Fixed-maturity investments, held as trading... $ 9,250 $ 11,118 Fixed-maturity investments, held as availablefor sale... 3,689 2,868 Funds withheld at interest... 2,560 3,076 Other investments Investment expenses... (711) (404) Net investment income... $ 15,003 $ 16,851 Realized and Unrealized Gains (Losses) The components of realized and unrealized gains (losses) on investments and other balances for the three month periods ended and 2016, were as follows: Three Month Period Ended March 31, 2017 Three Month Period Ended March 31, 2016 Realized and unrealized gains (losses) Fixed-maturity investments Gross realized gains... $ 85 $ 102 Net unrealized gains (losses), trading securities... 7,248 (1,858) 7,333 (1,756) Other Cerberus Affiliated Fund* - realized and unrealized gains (losses)... - (1,647) Realized gains (losses) on modified coinsurance treaties... (12) (28) Other (8) (1,667) Net realized and unrealized gains (losses)... $ 7,325 $ (3,423) Change in unrealized gains (losses) on available-forsale investments, net Fixed-maturity investments... 2,816 6,290 Common stock investments Change in deferred income taxes... (72) - Change in deferred acquisition costs... (209) - Unrealized gains (losses) on available-for-sale investments, net of taxes and deferred acquisition costs... $ 2,591 $ 6,290 * Defined in the Affiliated Investments section in this Note. 13

15 3. Investments (continued) Affiliated Investments Affiliated investments represented investments accounted for under the equity method, in accordance with FASB ASC 323 Investments Equity Method and Joint Ventures, for which the resulting equity method carrying value is deemed to approximate fair value. The investments accounted for under the equity method represented executed subscription documents, signed by SALIC on March 26, 2012, pursuant to which SALIC committed to make an investment of up to an aggregate $30.0 million in an investment fund affiliated with and controlled, directly or indirectly, by Cerberus (the Cerberus Affiliated Fund ). On December 1, 2016, SALIC entered into an agreement to sell to a third-party purchaser, in a privatelynegotiated transaction, its investment in the Cerberus Affiliated Fund for approximately $35.9 million. The cost (capital commitment) of the Cerberus Affiliated Fund by SALIC at the time of the transaction was approximately $28.9 million. The carrying value of the Cerberus Affiliated Fund at the time of the transaction was approximately $41.8 million. In accordance with FASB ASC Topic 323, the Company recorded a $5.9 million realized loss in the fourth quarter of 2016 on the Cerberus Affiliated Fund. The $5.9 million realized loss on the Cerberus Affiliated Fund investment was included in the Consolidated Statements of Comprehensive Income for the year ended December 31, 2016, under the caption, Net unrealized and unrealized gains (losses). 4. Fair Value Measurements FASB ASC 820 Fair Value Measurements and Disclosures ( FASB ASC 820 ) defines fair value, establishes a framework for measuring fair value based on an exit price definition, establishes a fair value hierarchy based on the quality of inputs used to measure fair value, and provides disclosure requirements for fair value measurements. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements), as described in Note 5, Fair Value Measurements in our audited consolidated financial statements and accompanying notes thereto for the year ended December 31, 2016, which, along with Note 3, Investments above, also includes additional disclosures regarding our fair value measurements. 14

16 4. Fair Value Measurements (continued) Fair Value Measurements on a Recurring Basis The following tables set forth our assets and liabilities that were measured at fair value on a recurring basis, as of the dates indicated: Level 1 Level 2 Level 3 Total Investments trading U.S. Treasury securities and U.S. government agency obligations... $ - $ 16,502 $ - $ 16,502 Corporate securities ,090 5, ,912 Municipal bonds ,119-26,119 Residential mortgage-backed securities , , ,802 Commercial mortgage-backed securities , ,250 Asset-backed securities ,753 24, ,897 Fixed-maturity investments, held as trading , , ,482 Investments available-for-sale U.S. Treasury securities and U.S. government agency obligations... $ - $ 23,646 $ - $ 23,646 Corporate securities , ,614 Municipal bonds ,580-2,580 Residential mortgage-backed securities ,236-12,236 Commercial mortgage-backed securities ,938-25,938 Asset-backed securities ,465 2, ,471 Fixed-maturity investments, held as available-forsale ,479 2, ,485 Common stock ,970-15,970 Total investments, held as available-for-sale ,449 2, ,455 Total assets at fair value... $ - $ 1,217,607 $ 291,330 $ 1,508,937 Embedded derivative liabilities (13,282) (13,282) Total liabilities at fair value... $ - $ - $ (13,282) $ (13,282) 15

17 4. Fair Value Measurements (continued) December 31, 2016 Level 1 Level 2 Level 3 Total Investments trading U.S. Treasury securities and U.S. government agency obligations... $ - $ 17,682 $ - $ 17,682 Corporate securities ,323 5, ,161 Municipal bonds ,167-26,167 Residential mortgage-backed securities , , ,126 Commercial mortgage-backed securities , ,129 Asset-backed securities ,226 24, ,624 Fixed-maturity investments, held as trading , ,391 1,000,889 Investments available-for-sale U.S. Treasury securities and U.S. government agency obligations... $ - $ 23,635 $ - $ 23,635 Corporate securities , ,457 Municipal bonds Residential mortgage-backed securities ,448-4,448 Commercial mortgage-backed securities ,670-25,670 Asset-backed securities , ,918 Fixed-maturity investments, held as available-forsale , ,128 Total assets at fair value... $ - $ 1,189,567 $ 289,450 $ 1,479,017 Embedded derivative liabilities (15,640) (15,640) Total liabilities at fair value... $ - $ - $ (15,640) $ (15,640) 16

18 4. Fair Value Measurements (continued) The following tables present additional information about our assets and liabilities measured at fair value on a recurring basis for which we have utilized significant unobservable (Level 3) inputs to determine fair values: Fair Value Measurements Using Significant Unobservable Inputs (Level 3) for the three month period ended Corporate securities Municipal bonds Residential mortgagebacked securities Commercial mortgagebacked securities Assetbacked securities Total assets at fair value Total liabilities at fair value Beginning balance as of January 1, $ 5,838 $ - $ 259,144 $ 11 $ 24,457 $ 289,450 $ (15,640) Total realized and unrealized gains (losses) included on trading securities in net income , ,110 2,358 Total unrealized gains (losses) included on available-for-sale securities in comprehensive net income (loss) Purchases ,974 1,974 - Settlements... (46) - (6,574) (11) (475) (7,106) - Accretion (amortization) , ,901 - Transfers into and/or (out of) Level 3, net Ending balance as of March 31, $ 5,822 $ - $ 259,358 $ - $ 26,150 $ 291,330 $ (13,282) 17

19 4. Fair Value Measurements (continued) Fair Value Measurements Using Significant Unobservable Inputs (Level 3) for the year ended December 31, 2016 Corporate securities Municipal bonds Residential mortgagebacked securities Commercial mortgagebacked securities Assetbacked securities Total assets at fair value Changes in classifications impacting Level 3 financial instruments were reported in the above tables as transfers into (out of) the Level 3 category at the end of each quarterly period in which the transfers occurred. The portion of net unrealized gains for the three month periods ended that related to Level 3 trading and availablefor-sale securities still held at the reporting dates was $3.2 million in net gains. The portion of net unrealized gains and losses for the three month periods ended March 31, 2016 related to Level 3 trading and available-for-sale securities still held at the reporting dates was $4.3 million of net losses. Total liabilities at fair value Beginning balance as of January 1, $ 6,996 $ - $ 267,849 $ 121 $ 26,110 $ 301,076 $ (16,871) Total realized and unrealized gains (losses) included on trading securities in net income... (191) - (47) 2 15 (221) 1,231 Total unrealized gains (losses) included on available-for-sale securities in comprehensive net income (loss) (742) - (2) (744) - Purchases Settlements... (1,067) - (23,088) (113) (1,352) (25,620) - Accretion (amortization) , ,338 - Transfers into and/or (out of) Level 3, net (379) (379) - Ending balance as of December 31, $ 5,838 $ - $ 259,144 $ 11 $ 24,457 $ 289,450 $ (15,640) 18

20 4. Fair Value Measurements (continued) The following tables summarizes the fair values, the valuation techniques, and significant unobservable inputs of the Level 3 fair value measurements as of and December 31, 2016, for which we have been able to obtain quantitative information about the significant unobservable inputs used in those fair value measurements: Assets (U.S. dollars in millions) Fair Value Corporate securities... $ 1,720 Mortgage and asset-backed securities... $ 10,121 Valuation Technique Discounted Cash Flow Discounted Cash Flow Significant Unobservable Inputs Input Ranges Liquidity/duration adjustment* 1.1% - 1.5% Liquidity/duration adjustment* 1.5% - 1.6% Assets (U.S. dollars in millions) Fair Value Corporate securities... $ 1,761 Mortgage and asset-backed securities... $ 10,228 December 31, 2016 Valuation Technique Discounted Cash Flow Discounted Cash Flow Significant Unobservable Inputs Input Ranges Liquidity/duration adjustment* 1.1% - 1.7% Liquidity/duration adjustment* 1.5% - 1.6% * The liquidity/duration adjustment input represents an estimated market participant composite interest spread that would be applied to the risk-free rate to discount the estimated projected cash flows for individual securities, and such liquidity/duration adjustment would reflect adjustments attributable to liquidity premiums, expected durations, credit structures, credit quality, etc., as applicable. We have excluded from the tables above Level 3 fair value measurements obtained from independent, thirdparty pricing sources, including prices obtained from brokers, for which we do not develop the significant inputs used to measure the fair values and information regarding the significant inputs is not readily available to us from the independent, third-party pricing sources or brokers. Fair Value Measurements on a Non-Recurring Basis As disclosed in this Note, the fair values of financial assets and liabilities are estimated in accordance with the framework established under FASB ASC 820. The methodology for determining the fair value of financial instruments on a non-recurring basis, in addition to the fair value of financial instruments on a recurring basis and to those disclosed above in Note 3, Investments, are described in Note 2, Summary of Significant Accounting Policies - Investments, and Note 5, Fair Value Measurements in the Company s audited consolidated financial statements and accompanying notes thereto for the year ended December 31, The following table sets forth the fair values of our financial instruments, as of the dates indicated: 19

21 4. Fair Value Measurements (continued) Carrying Balance Level 1 Level 2 Level 3 Estimated Fair Value Assets Cash and cash equivalents... $ 186,435 $ 186,435 $ - $ - Other investments... 2, ,325 Funds withheld at interest , ,688 Accrued interest receivable... 9,005-9,005 - Liabilities Interest-sensitive contract liabilities... $ 752,678 $ - $ - $ 752,126 Collateral finance facility, excluding debt issuance costs , ,007 Embedded derivative liabilities, at fair value... 13, ,282 Long-term debt, at par value... 86,500-52,544 - December 31, 2016 Carrying Balance Level 1 Level 2 Level 3 Estimated Fair Value Assets Cash and cash equivalents... $ 194,920 $ 194,920 $ - $ - Other investments... 2, ,368 Funds withheld at interest , ,761 Accrued interest receivable... 9,219-9,219 - Liabilities Interest-sensitive contract liabilities... $ 765,610 $ - $ - $ 765,069 Collateral finance facility, excluding debt issuance costs , ,601 Embedded derivative liabilities, at fair value... 15, ,640 Long-term debt, at par value... 86,500-51, Collateral Finance Facility and Securitization Structure Orkney Re II Historical information regarding the Orkney Re II collateral finance facility and securitization structure is discussed in Note 7, Collateral Finance Facility and Securitization Structure Orkney Re II in the Company s audited consolidated financial statements and accompanying notes thereto for the year ended December 31, The following table reflects the significant balances included in the accompanying Consolidated Balance Sheets that were attributable to the Orkney Re II collateral finance facility and securitization structure providing collateral support to the Company: 20

22 5. Collateral Finance Facility and Securitization Structure (continued) March 31, 2017 December 31, 2016 Assets Fixed-maturity investments held as available-for-sale securities, at fair value... $ 8,072 $ 8,072 Funds withheld at interest , ,623 Cash and cash equivalents... 3,383 3,422 Embedded derivative assets... 51,896 50,044 All other assets... 5,822 5,211 Total assets... $ 446,728 $ 443,372 Liabilities Reserves for future policy benefits... $ 128,440 $ 130,106 Collateral finance facility, net of debt issuance costs , ,056 All other liabilities... 81,717 78,030 Total liabilities... $ 658,323 $ 652,192 The assets listed in the foregoing table are subject to a variety of restrictions on their use, as set forth in and governed by the transaction documents for the Orkney Re II collateral finance facility and securitization structure. The total investments of the consolidated VIE disclosed in the accompanying Consolidated Balance Sheets include the deduction of the assets needed to satisfy future policy benefits, based on current projections ( economic reserves ). The following table provides a reconciliation of the aforementioned adjustments: March 31, 2017 December 31, 2016 Fixed-maturity investments held as availablefor-sale securities, at fair value... $ 8,072 $ 8,072 Funds withheld at interest , ,623 Cash and cash equivalents... 3,383 3,422 Embedded derivative assets... 51,896 50,044 Total investments... $ 440,906 $ 438,161 Less: Economic reserves... (158,062) (159,945) Total investments in consolidated VIE... $ 282,844 $ 278,216 The reinsurance liabilities of Orkney Re II have been eliminated from the Consolidated Balance Sheets. Orkney Re II - Settlement of Litigation On March 25, 2017, Orkney Re II agreed in principle to settle litigation brought by Assured, the guarantor of the Series A-1 Notes of Orkney Re II, in Assured s own right and in the right of Orkney Re II, against J.P. Morgan Investment Management, Inc. ( JPMIM ), the former investment manager of Orkney Re II, relating to the management of Orkney Re II's investment accounts, which were funded with the proceeds of the Orkney Re II Notes, as explained in Note 7, Collateral Finance Facility and Securitization Structure in the Company s audited consolidated financial statements and accompanying notes thereto for the year ended December 31,

23 5. Collateral Finance Facility and Securitization Structure (continued) Assured, suing in its own right and on behalf of Orkney Re II, commenced litigation against JPMIM in the Supreme Court of the State of New York on or about May 13, The legal proceedings have been ongoing since 2009, and up until the date of the settlement of March 25, 2017, there was no assurances over the outcome of the litigation. For further discussion on the Orkney Re II settlement of litigation, please refer to Note 11, Subsequent Events - Orkney Re II Settlement of Litigation. Orkney Re II Event of Default, Acceleration, and Foreclosure Orkney Re II has been unable to make scheduled interest payments on the Series A-1 Notes and Series A-2 Notes on all scheduled quarterly interest payment dates since May 11, As of, Assured Guaranty (UK) Ltd. ( Assured ) has made guarantee payments in the cumulative amount of $25.9 million on the Series A-1 Notes which are the subject of a financial guaranty policy issued by Assured in connection with the Orkney Re II transaction. Unlike the Series A-1 Notes, the Series A-2 Notes were not guaranteed under the Orkney Re II transaction and the amount of cumulative interest on the Series A-2 Notes was $3.9 million as of March 31, We have accrued this amount of cumulative interest on the Series A-1 Notes and the Series A-2 Notes in Accounts Payable and Other Liabilities in the Consolidated Balance Sheets. Interest on the Series A-1 Notes on which Assured is making guarantee payments is payable quarterly at a rate equivalent to three-month LIBOR plus 0.425%. As of, the interest rate on the Series A-1 Notes was 1.46% (compared to 1.31% as of December 31, 2016). Interest on the Series A-2 Notes, which are not guaranteed as part of the Orkney Re II transaction, is payable quarterly at a rate equivalent to three-month LIBOR plus 0.730%. As of, the interest rate on the Series A-2 Notes was 1.76% (compared to 1.62% as of December 31, 2016). For further discussion on Orkney Re II and scheduled interest payments on the Series A-1 Notes and the Series A-2 Notes, please refer to Note 11, Subsequent Events - Orkney Re II Scheduled Interest Payments. 22

24 6. Debt Obligations and Other Funding Arrangements Long-term debt, at par value (collectively, the Capital and Trust Preferred Securities ), is individually defined and described in Note 8, Debt Obligations and Other Funding Arrangements in the notes accompanying the Company s audited consolidated financial statements for the year ended December 31, The pertinent details regarding long-term debt, at par value are shown in the following table: Capital Securities Due 2032* Preferred Trust Securities Due 2033* Trust Preferred Securities Due 2033* Trust Preferred Securities Due 2034* Trust Preferred Securities Due December 2034* Issuer of long-term debt... Capital Trust* Capital Trust II* GPIC Trust* Capital Trust III* SFL Trust I* Long-term debt outstanding... $17,500 $nil** $nil*** $19,000**** $50,000 Maturity date... Dec 4, 2032 Oct 29, 2033 Sept 30, 2033 June 17, 2034 Dec 15, 2034 Redeemable (in whole or in part) after... Dec 4, 2007 Oct 29, 2008 Sept 30, 2008 June 17, 2009 Dec 15, 2009 Interest Payable... Quarterly Quarterly Quarterly Quarterly Quarterly Interest rate: 3-month LIBOR % 3.95% 3.90% 3.80% 3.50% Interest rate as of % 5.10% 5.05% 4.95% 4.65% Interest rate as of December 31, % 4.95% 4.90% 4.80% 4.50% Maximum number of quarters for which interest may be deferred Number of quarters for which interest has been deferred as of * Defined in the notes accompanying SRGL s audited consolidated financial statements for the year ended December 31, **SRGL owns all $20.0 million of the Preferred Trust Securities Due 2033 securities. ***SRGL owns all $10.0 million of the Trust Preferred Securities Due 2033 securities. ****SRGL owns $13.0 million of the Trust Preferred Securities Due 2034 securities. Deferral of Interest Payments on the Capital and Trust Preferred Securities We began deferring interest payments as of January 29, 2013 on the Capital and Trust Preferred Securities as permitted by the terms of the indentures governing the securities. As of, we had accrued and deferred payments of $25.1 million in interest on the Capital and Trust Preferred Securities. Of these deferred payments, $8.6 million are attributable to SRGL, leaving a net amount of accrued deferred interest of $16.5 million on the Capital and Trust Securities due to external parties. SHI, SFL, and SALIC generally are restricted in their ability to make certain dividend payments and payments in respect of obligations ranking junior or pari passu to the Capital and Trust Preferred Securities in any period where interest payment obligations on these securities are not current. For further discussion on the accrued and deferred payment on our Capital and Trust Preferred Securities subsequent to, please refer to Note 11, Subsequent Events Deferral of Interest Payments on the Capital and Trust Preferred Securities. 7. Mezzanine Equity Convertible Cumulative Participating Preferred Shares On May 7, 2007, we completed the equity investment transaction by the Investors, announced by us on November 27, 2006 (the 2007 New Capital Transaction ). Pursuant to the 2007 New Capital Transaction, the 23

25 7. Mezzanine Equity Convertible Cumulative Participating Preferred Shares (continued) Investors invested an aggregate $600.0 million in the Company in exchange for 1,000,000, in the aggregate, newlyissued Convertible Cumulative Participating Preferred Shares (the CCPP Shares ). Aggregate net proceeds of $555.9 million were received after payment of $44.1 million in closing costs. Each CCPP Share had a par value of $0.01 per share with an initial stated value and liquidation preference of $600 per share, as adjusted for the accretion of dividends or the payment of dividends or distributions as described further below. The CCPP Shares were convertible at the option of the holder, at any time, into an aggregate of 150,000,000 ordinary shares (the Ordinary Shares ) of SRGL. We accounted for the 2007 issuance of the CCPP Shares to the Investors, in accordance with FASB ASC Subtopic , Debt Debt with Conversion and Other Options ( FASB ASC ), which incorporates EITF D-98: Classification and Measurement of Redeemable Securities. We were not required at any time to redeem the CCPP Shares for cash, except in the event of a liquidation or upon the occurrence of a change-in-control event. On the ninth anniversary of issue, May 7, 2016, and in accordance with the CCPP Certificate of Designations, the CCPP Shares automatically converted into an aggregate of 150,000,000 Ordinary Shares of the Company. We accounted for the conversion of the CCPP Shares in accordance with FASB ASC As a result, and in accordance with the CCPP Certificate of Designations, the CCPP Shares were converted into an aggregate of 150,000,000 Ordinary Shares, with each Ordinary Share having a par value of $0.01, representing an additional $1.5 million in the Ordinary Shares amount in the Company's Consolidated Balance Sheets. The remaining balance of the CCPP Shares amount of approximately $554.4 million that was previously classified under Mezzanine Equity in the Consolidated Balance Sheets, and was over and above the Ordinary Share conversion amount of $1.5 million as described earlier, was reclassified to Additional Paid-in Capital ( APIC ). The conversion of the CCPP Shares had no material impact on the results of operations of the Company and only impacted the Consolidated Balance Sheets and Consolidated Statements of Shareholders Equity. The table below provides an illustration of the changes to the Company's Consolidated Balance Sheets during 2016 as follows: May 6, 2016 Adjustment May 7, 2016 Total Mezzanine Equity Total Mezzanine Equity... $ 555,857 $ (555,857) $ - Total Mezzanine Equity... $ 555,857 $ (555,857) $ - Equity Share Capital... $ 684 $ 1,500 $ 2,184 APIC... 1,218, ,357 1,772,547 Share Capital & APIC... $ 1,218,874 $ 555,857 $ 1,774,731 24

26 8. Shareholders' Deficit Ordinary Shares SCOTTISH RE GROUP LIMITED We are authorized to issue 590,000,000 Ordinary Shares with a par value of $0.01 per share. As of and December 31, 2016, we had 218,383,370 Ordinary Shares issued and outstanding. Perpetual Preferred Shares We are authorized to issue 50,000,000 preferred shares with a par value of $0.01 per share. In 2005, we issued 5,000,000 non-cumulative Perpetual Preferred Shares (the Perpetual Preferred Shares ). Gross proceeds were $125 million, and related expenses were $4.6 million. As of, we have repurchased and cancelled 1,753,224 Perpetual Preferred Shares. As of and December 31, 2016, we had 3,246,776 Perpetual Preferred Shares issued and outstanding. The dividend rate on the Perpetual Preferred Shares may be at a fixed rate determined through remarketing of the Perpetual Preferred Shares for specific periods of varying length not less than six months or may be at a floating rate reset quarterly based on a predefined set of interest rate benchmarks. The quarterly floating rates for March 31, 2017 and 2016 were 6.39% and 6.09% respectively. During any dividend period, unless the full dividends for the current dividend period on all outstanding Perpetual Preferred Shares have been declared or paid, no dividend may be paid or declared on the Ordinary Shares and no Ordinary Shares or other junior shares may be purchased, redeemed, or otherwise acquired for consideration by SRGL. Please refer below to Dividends on Perpetual Preferred Shares in the Note below for additional information. Dividends on Ordinary Shares The Investors, as the holders of the Ordinary Shares, are entitled to receive dividends and are allowed one vote per share subject to certain restrictions in our Memorandum and Articles of Association. All future payments of dividends are at the discretion of our Board and will depend on such factors as the Board may deem relevant. Notwithstanding the foregoing, if dividends on the Perpetual Preferred Shares have not been declared and paid (or declared and a sum sufficient for the payment thereof set aside) for a dividend period, we generally are precluded from paying or declaring any dividend on the Ordinary Shares. Dividends on Perpetual Preferred Shares In accordance with the relevant financial tests under the terms of the Perpetual Preferred Shares, our Board was precluded from declaring and paying a dividend in connection with the January 15, April 15, and July 15, 2016 dividend payment dates. In accordance with the relevant financial tests under the terms of the Perpetual Preferred Shares, our Board was permitted to declare and pay a dividends for the October 15, 2016 payment date and the January 15, 2017 payment date. Our Board resolved, in its discretion, not to declare and pay a dividend on the Perpetual Preferred Shares on the October 15, 2016 and the January 15, 2017 dividend payment dates. There can be no assurances when or whether, as a result of the application of the financial tests contained in the terms of the Perpetual Preferred Shares, our Board will be permitted to make subsequent dividend payments on the Perpetual Preferred Shares or, if permitted, when or whether our Board will choose in its discretion to make any such dividend payments on the Perpetual Preferred Shares. For further discussion on the non-declaration of the 25